Lamictal en es it fr

Lamictal Brand names, Lamictal Analogs

Lamictal Brand Names Mixture

  • No information avaliable

Lamictal Chemical_Formula


Lamictal RX_link

Lamictal fda sheet

Lamictal FDA

Lamictal msds (material safety sheet)

Lamictal MSDS

Lamictal Synthesis Reference

M. G. Baxter et al., Eur. pat. Appl. 21,121 (1981 to Wellcome Foundation); D. A. Sawyer et al., U.S. pat. 4,602,017 (1986)

Lamictal Molecular Weight

256.091 g/mol

Lamictal Melting Point

216-218 oC (uncorr)

Lamictal H2O Solubility

No information avaliable

Lamictal State


Lamictal LogP


Lamictal Dosage Forms

Tablet; Chewable

Lamictal Indication

For the adjunctive treatment of partial seizures in epilepsy and generalized seizures of Lennox-Gastaut syndrome; For the maintenance treatment of Bipolar I Disorder

Lamictal Pharmacology

Lamotrigine, an antiepileptic drug (AED) of the phenyltriazine class, is chemically unrelated to existing antiepileptic drugs. Lamotrigine is also used in the treatment of depression and bipolar disorder. Lamotrigine is thought to exert its anticonvulsant effect by stabilizing presynaptic neuronal membranes. Lamotrigine inhibits sodium currents by selectively binding to the inactivated state of the sodium channel and subsequently suppresses the release of the excilatory amino acid, glutamate.

Lamictal Absorption


Lamictal side effects and Toxicity

LD50=250 (mg/kg) (in rat, mice); LD50>640 orally (mg/kg) (in rat, mice) (Sawyer); Decreased level of consciousness, coma, delayed heartbeat, increased seizures, lack of coordination, rolling eyeballs

Lamictal Patient Information

Lamictal Organisms Affected

Humans and other mammals